logo

FDA Calendar

Share SHARE
Company Name Eli Lilly And Co.
Drug Name Abemaciclib (NDA)
Event Name FDA decision on Abemaciclib for the treatment of advanced breast cancer
Event Date 01/10/2018
Outcome Date
Outcome
Drug Status Priority review
Rival Drugs
Market Potential
Other Approvals
News
Return to FDA Calendar